April 04, 2022 at 02:51PM CINRYZE

Product approval information is indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with Hereditary Angioedema (HAE).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2CNeUBy